Jesús Sojo-Dorado

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, Alberto M. Borobia, Antonio J. Carcas et al. · The Lancet Infectious Diseases · 2021 · 102 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +13

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant <i>Escherichia coli</i> Bacteremic Urinary Tract Infections

Jesús Sojo-Dorado, Inmaculada López-Hernández, Clara Rosso-Fernández et al. · JAMA Network Open · 2022 · 87 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing <i>Escherichia coli</i> (FOREST): study protocol for an investigator-driven randomised controlled trial

Clara Rosso-Fernández, Jesús Sojo-Dorado, Ángel Díaz Barriga et al. · BMJ Open · 2015 · 65 citations · Full text

Pharmacy, Microbiology, Pharmacotherapy +17

Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

Salvador Pérez-Galera, José María Bravo-Ferrer, María Paniagua‐García et al. · EClinicalMedicine · 2023 · 60 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)

María Paniagua‐García, José María Bravo-Ferrer, Salvador Pérez-Galera et al. · Clinical Microbiology and Infection · 2024 · 43 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15